Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Inflammatory Bowel Diseases

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00054725-200405000-00013PMID 15290921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

  2002influential reference
• REVIEW: Role of 5-Aminosalicylic Acid (5-ASA) in Treatment of Inflammatory Bowel Disease: A Systemic Review

  2002cited by this paper
• Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

  2002cited by this paper
• [Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid: case report and review of the literature].

  1999cited by this paper
• Controlled Trial of 4-ASA in Ulcerative Colitis

  1997cited by this paper
• Adverse events in patients treated with 5‐aminosalicyclic acid: 1993–1994 pharmacovigilance report for Pentasa in France

  1996cited by this paper
• [Comparative randomized open study of the efficacy and tolerance of enemas with 2 gr of 4-amino-salicylic acid (4-ASA) and 1 gr of 5-amino-salicylic acid (5-ASA) in distal forms of hemorrhagic rectocolitis].

  1995cited by this paper
• Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis.

  1994cited by this paper
• Pharmacology of the antimycobacterial drugs.

  1993cited by this paper
• Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis.

  1992cited by this paper
• Placebo-controlled trial of ulcerative colitis with oral 4-aminosalicylic acid.

  1992cited by this paper
• A prospective randomized double blind trial comparing prednisolone and 4‐aminosalicylic acid enemas in acute distal ulcerative colitis

  1992cited by this paper
• Availability of mesalazine (5-aminosalicylic acid) from enemas and suppositories during steady-state conditions.

  1991cited by this paper
• Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial.

  1988cited by this paper
• 4-Aminosalicylic acid retention enemas in treatment of distal colitis

  1987cited by this paper
• [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France].

  1985cited by this paper
• Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France

  1985cited by this paper
• A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis.

  1984cited by this paper
• Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas.

  1984cited by this paper
• Hypersensitivity to para-aminosalicylic acid.

  1960cited by this paper

• Lab-on-a chip electrochemical sensing platform for simultaneous, ultra-sensitive and on-spot detection of 4-aminosalicylic acid and 5-aminosalicylic acid based on synergistic potential of chitosan functionalized MWCNTs supported on Ni doped Bi2S3.

  2025cites this paper
• Mesalazine-Induced Acute Pancreatitis in Inflammatory Bowel Disease Patients: A Systematic Review

  2025cites this paper
• Hybrids of 4-aminosalicylic acid with dual anti-mycobacterial and anti-inflammatory activities: Synthesis, biological evaluation, in silico investigation and structure-activity relationships exploration

  2024cites this paper
• Drug-Induced Acute Pancreatitis: An Evidence-Based Classification (Revised)

  2023cites this paper
• Fermented Glutinous Rice Extract Mitigates DSS-Induced Ulcerative Colitis by Alleviating Intestinal Barrier Function and Improving Gut Microbiota and Inflammation

  2023cites this paper
• Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents.

  2023cites this paper
• IBD Clinical

  2021cites this paper
• The impact of fluid resuscitation via colon on patients with severe acute pancreatitis

  2021cites this paper
• Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug

  2020cites this paper
• Computational study of noncovalent interactions within the various complexes of para aminosalicylic acid and Cr2+, Mn+, Fe2+, Co+, Ni2+, Cu+, Zn2+ cations: exploration of the enhancing effect of the cation–π interaction on the intramolecular hydrogen bond

  2020cites this paper
• Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations

  2020cites this paper
• Retrospective Matched-Cohort Analysis of Acute Pancreatitis Induced by 5-Aminosalicylic Acid–Derived Drugs

  2019cites this paper
• Aminosalicylic acid reduces ER stress and Schwann cell death induced by MPZ mutations

  2019cites this paper
• Discovery of small-molecule candidates against inflammatory bowel disease.

  2019cites this paper
• Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.

  2016cites this paper
• Probing the Association of Pancreatitis in Inflammatory Bowel Disease

  2016influential citation
• Pancreatitis inducida por mesalacina en pacientes con enfermedad inflamatoria intestinal

  2015cites this paper
• Influence of isomerism on recrystallization and cocrystallization induced by CO2 as an antisolvent

  2015cites this paper
• Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease.

  2014cites this paper
• Peucedanum japonicum Thunberg Leaf Alleviates the Symptoms of Dextran Sulfate Sodium Induced Ulcerative Colitis in Mice

  2014cites this paper
• Salicylates and the Microbiota: A New Mechanistic Understanding of an Ancient Drug's Role in Dermatological and Gastrointestinal Disease

  2013cites this paper
• Protective effects of ebselen (Ebs) and para-aminosalicylic acid (PAS) against manganese (Mn)-induced neurotoxicity.

  2012cites this paper
• Interaction of 4-aminosalicylic acid and surfactants in aqueous solutions using UV-Vis spectra and steady-state fluorescence spectroscopy

  2011cites this paper
• Co-drugs of aminosalicylates and nutraceutical amino sugar for ulcerative colitis

  2011cites this paper
• Rational design and development of colon-specific prodrugs.

  2011cites this paper
• Pancreatic Involvement in Patients with Inflammatory Bowel Disease

  2010cites this paper
• Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.

  2009cites this paper
• Synthesis and theoretical calculations of 5-aminosalicylic acid derivatives as potential analgesic agents.

  2008cites this paper
• Aminosalicylic acid conjugates of EDTA as potential anti-inflammatory pro-drugs: synthesis, copper chelation and superoxide dismutase-like activities

  2007cites this paper
• Acute pancreatitis as a possible consequence of metronidazole during a relapse of ulcerative colitis.

  2007cites this paper
• 36 - Gastrointestinal drugs

  2007cites this paper
• Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

  2006cites this paper
• Drug evolution concept in drug design: 2. Chimera method.

  2006cites this paper